Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?

Del Papa, Nicoletta; Sambataro, Gianluca; Minniti, Antonina; Pignataro, Francesca; Caporali, Roberto

Del Papa, Nicoletta; Sambataro, Gianluca; Minniti, Antonina; Pignataro, Francesca; Caporali, Roberto.

Del Papa N; Department of Rheumatology, Gaetano Pini Hospital, Milan, Italy. Electronic address: Nicoletta.DelPapa@asst-pini-cto.it.
Sambataro G; Regional Referral Center for Rare Lung Diseases, Department of Clinical and Experimental Medicine, University of Catania, Italy.
Minniti A; Department of Rheumatology, Gaetano Pini Hospital, Milan, Italy.
Pignataro F; Department of Rheumatology, Gaetano Pini Hospital, Milan, Italy.
Caporali R; Department of Rheumatology, Gaetano Pini Hospital, Milan, Italy; University of Milan, Dept. of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Milan, Italy.

Autoimmun Rev ; 19(7): 102558, 2020 07.

Article in English | MEDLINE | ID: covidwho-249405

Subject(s)

Arthritis; Coronavirus; Scleroderma, Systemic; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2

Keywords

Coronavirus; Interstitial lung disease; Systemic sclerosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis / Scleroderma, Systemic / Coronavirus Type of study: Prognostic study Limits: Humans Language: English Journal: Autoimmun Rev Journal subject: Allergy and Immunology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google